Target：ACY1

Fields：Arginine biosynthesis;Metabolic pathways;2-Oxocarboxylic acid metabolism;Biosynthesis of amino acids

Gene Name：ACY1

Protein Name：Aminoacylase-1 (ACY-1) (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase)

Human Gene Id：95

Human Swiss Prot No：Q03154

Mouse Swiss Prot No：Q99JW2

Immunogen：Synthesized peptide derived from part region of human protein

Specificity：ACY1 Polyclonal Antibody detects endogenous levels of protein.

Formulation：Liquid in PBS containing 50% glycerol, and 0.02% sodium azide.

Source：Polyclonal, Rabbit,IgG

Dilution：WB 1:500-2000 ELISA 1:5000-20000

Purification：The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration：1 mg/ml

Storage Stability：-15°C to -25°C/1 year(Do not lower than -25°C)

Observed Band(KD)：44kD

Background： This gene encodes a cytosolic, homodimeric, zinc-binding enzyme that catalyzes the hydrolysis of acylated L-amino acids to L-amino acids and an acyl group, and has been postulated to function in the catabolism and salvage of acylated amino acids. This gene is located on chromosome 3p21.1, a region reduced to homozygosity in small-cell lung cancer (SCLC), and its expression has been reported to be reduced or undetectable in SCLC cell lines and tumors. The amino acid sequence of human aminoacylase-1 is highly homologous to the porcine counterpart, and this enzyme is the first member of a new family of zinc-binding enzymes. Mutations in this gene cause aminoacylase-1 deficiency, a metabolic disorder characterized by central nervous system defects and increased urinary excretion of N-acetylated amino acids. Alternative splicing of this gene results in multiple transcript variants. Read-through transcription als

Function：catalytic activity:An N-acyl-L-amino acid + H(2)O = a carboxylate + an L-amino acid.,cofactor:Binds 2 zinc ions per subunit.,disease:Defects in ACY1 are the cause of aminoacylase-1 deficiency (ACY1D) [MIM:609924]. ACY1D results in a metabolic disorder manifesting with encephalopathy, unspecific psychomotor delay, psychomotor delay with atrophy of the vermis and syringomyelia, marked muscular hypotonia or normal clinical features. Epileptic seizures are a frequent feature. All affected individuals exhibit markedly increased urinary excretion of several N-acetylated amino acids.,function:Involved in the hydrolysis of N-acylated or N-acetylated amino acids (except L-aspartate).,similarity:Belongs to the peptidase M20A family.,subunit:Homodimer. Interacts with SPHK1.,tissue specificity:Expression is highest in kidney, strong in brain and weaker in placenta and spleen.,

Subcellular Location：Cytoplasm.

Expression：Expression is highest in kidney, strong in brain and weaker in placenta and spleen.